Melanóma: vizsgálatok itt: Olaszország
61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Where
- Candiolo, Milan, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 15 worldwide
- Run by
- Valo Therapeutics Oy
See details and how to joinNCT05492682 · EU 2024-517580-23-00 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Bergamo, Milan, Naples, Perugia, Siena
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - No phaseNot yet taking people in OlaszországGut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
- Where
- Milan
- Életkor
- 18 év and over
- People
- 360
- Run by
- European Institute of Oncology
See details and how to joinNCT07815873 - 1. fázisNot yet taking people in OlaszországA Multicentre, open label, Phase I-Ib Clinical Trial Combining Melanoma-Specific Peptide Vaccination (UniCanVax) and Anti PD-1 Inhibitor (Nivolumab) in Immune Checkpoint Blockade Refractory Metastatic or Unresectable Stage III/IV Melanoma Patients
- Where
- Milan, Naples, Padova, Perugia, Rozzano
- Életkor
- 18 év and over
- People
- 25
- Run by
- Humanitas Mirasole S.p.A.
See details and how to join2025-524486-25-00 · EU 2025-524486-25-00 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Bergamo, Brescia, Ferrara, Florence, Milan, Modena, Pavia, Verona
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 3. fázisTaking peopleStudy to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
- Where
- Catanzaro, Siena
- Életkor
- 18 év and over
- People
- 632 worldwide
- Run by
- mAbxience Research S.L.
See details and how to joinNCT07221734 - 1. fázisNot yet taking people in OlaszországA Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL-2 Superkine MDNA11 alone or with Tocilizumab in Patients with High-Risk, Surgically Resectable Melanoma – NEO-CYT
- Where
- Meldola, Milan, Naples, Padova, Perugia, Rome
- Életkor
- 18 év and over
- People
- 80
- Run by
- Fondazione Melanoma Onlus
See details and how to join2024-519010-31-00 · EU 2024-519010-31-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisTaking peopleA PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III melanoma in the adjuvant setting
- Where
- Ancona, Brescia, Naples, Rome
- Életkor
- 18 év and over
- People
- 83 worldwide
- Run by
- H e x a l AG
See details and how to join2025-521919-39-00 · EU 2025-521919-39-00 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Meldola, Milan, Naples, Roma, Rozzano
- Életkor
- 18 év and over
- People
- 1438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - No phaseNot yet taking people in OlaszországDermatological Effects and Quality of Life in Oncology Patients
- Where
- Milan
- Életkor
- 18 év and over
- People
- 300
- Run by
- European Institute of Oncology
See details and how to joinNCT07869186 - 2. fázisTaking peopleAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
- Where
- Naples
- Életkor
- 18 év to 120 év
- People
- 218 worldwide
- Run by
- Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Alexandria, Ancona, Bari, Bergamo, Candiolo, Genoa, Messina, Milan, Modena, Padova, Rome, San Giovanni Rotondo, Siena, Trento
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 2. fázisNot yet taking people in OlaszországPHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
- Where
- Bari, Milan, Naples
- Életkor
- 18 év and over
- People
- 46 worldwide
- Run by
- Therakos Europe Limited
See details and how to join2026-526261-14-00 · EU 2026-526261-14-00 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Aviano, Meldola, Milan, Naples, Pisa, Siena
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Meldola, Reggio Emilia, Roma
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleMELanoma Brain Metastasis Treated With CYberknife
- Where
- Milan
- Életkor
- 18 év and over
- People
- 50
- Run by
- European Institute of Oncology
See details and how to joinNCT07691255 - 1. fázisTaking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Naples
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - 2. fázisTaking peopleStudy of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
- Where
- Naples
- Életkor
- 18 év and over
- People
- 162 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT06284590 · EU 2024-519326-20-00 - 3. fázisCsak meghívásosA Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
- Where
- Florence, Milan, Rome
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 2. fázisTaking peoplePhase II study of Roginolisib in UM patients
- Where
- Bari, Naples, Padova, Rozzano, Siena
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- iOnctura SA
See details and how to join2024-514333-37-00 · EU 2024-514333-37-00 - 3. fázisTaking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Bari, Milan, Modena, Naples, Perugia, Rome, Siena
- Életkor
- 12 év and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - 1/2. fázisTaking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Rome
- Életkor
- 6 hónap to 17 év
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00